Global OTC and DTC Infectious Disease Diagnostic Market Research Report 2023

OTC and DTC Infectious Disease Diagnostic Market

In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements

The global OTC and DTC Infectious Disease Diagnostic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for OTC and DTC Infectious Disease Diagnostic in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of OTC and DTC Infectious Disease Diagnostic include Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC and DTC Infectious Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC and DTC Infectious Disease Diagnostic.

The OTC and DTC Infectious Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC and DTC Infectious Disease Diagnostic market comprehensively. Regional market sizes, concerning products by technology, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the OTC and DTC Infectious Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by technology, by application, and by regions.

Scope of OTC and DTC Infectious Disease Diagnostic Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Technology

1.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Technology: 2018 VS 2022 VS 2029

1.2.2 PCR

1.2.3 Immunodiagnostics

1.2.4 Clinical Microbiology

1.2.5 INAAT

1.2.6 DNA Sequencing and NGS

1.2.7 DNA Microarrays

1.2.8 Others

1.3 Market by Application

1.3.1 Global OTC and DTC Infectious Disease Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals and Clinics

1.3.4 Academic Research Institutes

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global OTC and DTC Infectious Disease Diagnostic Market Perspective (2018-2029)

2.2 OTC and DTC Infectious Disease Diagnostic Growth Trends by Region

2.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 OTC and DTC Infectious Disease Diagnostic Historic Market Size by Region (2018-2023)

2.2.3 OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Region (2024-2029)

2.3 OTC and DTC Infectious Disease Diagnostic Market Dynamics

2.3.1 OTC and DTC Infectious Disease Diagnostic Industry Trends

2.3.2 OTC and DTC Infectious Disease Diagnostic Market Drivers

2.3.3 OTC and DTC Infectious Disease Diagnostic Market Challenges

2.3.4 OTC and DTC Infectious Disease Diagnostic Market Restraints

3.1 Global Top OTC and DTC Infectious Disease Diagnostic Players by Revenue

3.1.1 Global Top OTC and DTC Infectious Disease Diagnostic Players by Revenue (2018-2023)

3.1.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Players (2018-2023)

3.2 Global OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by OTC and DTC Infectious Disease Diagnostic Revenue

3.4 Global OTC and DTC Infectious Disease Diagnostic Market Concentration Ratio

3.4.1 Global OTC and DTC Infectious Disease Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by OTC and DTC Infectious Disease Diagnostic Revenue in 2022

3.5 OTC and DTC Infectious Disease Diagnostic Key Players Head office and Area Served

3.6 Key Players OTC and DTC Infectious Disease Diagnostic Product Solution and Service

3.7 Date of Enter into OTC and DTC Infectious Disease Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global OTC and DTC Infectious Disease Diagnostic Historic Market Size by Technology (2018-2023)

4.2 Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Technology (2024-2029)

5.1 Global OTC and DTC Infectious Disease Diagnostic Historic Market Size by Application (2018-2023)

5.2 Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Application (2024-2029)

6.1 North America OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)

6.2 North America OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023)

6.4 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)

7.2 Europe OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023)

7.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)

8.2 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2023)

8.4 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)

9.2 Latin America OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023)

9.4 Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size (2018-2029)

10.2 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023)

10.4 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Introduction

11.1.4 Abbott Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.1.5 Abbott Recent Development

11.2 Bio-Rad Laboratories Inc

11.2.1 Bio-Rad Laboratories Inc Company Detail

11.2.2 Bio-Rad Laboratories Inc Business Overview

11.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Introduction

11.2.4 Bio-Rad Laboratories Inc Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.2.5 Bio-Rad Laboratories Inc Recent Development

11.3 BD

11.3.1 BD Company Detail

11.3.2 BD Business Overview

11.3.3 BD OTC and DTC Infectious Disease Diagnostic Introduction

11.3.4 BD Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.3.5 BD Recent Development

11.4 Bosch Healthcare Solutions GmbH

11.4.1 Bosch Healthcare Solutions GmbH Company Detail

11.4.2 Bosch Healthcare Solutions GmbH Business Overview

11.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Introduction

11.4.4 Bosch Healthcare Solutions GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.4.5 Bosch Healthcare Solutions GmbH Recent Development

11.5 Danaher

11.5.1 Danaher Company Detail

11.5.2 Danaher Business Overview

11.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Introduction

11.5.4 Danaher Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.5.5 Danaher Recent Development

11.6 ThermoFisher Scientific

11.6.1 ThermoFisher Scientific Company Detail

11.6.2 ThermoFisher Scientific Business Overview

11.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Introduction

11.6.4 ThermoFisher Scientific Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.6.5 ThermoFisher Scientific Recent Development

11.7 Siemens AG

11.7.1 Siemens AG Company Detail

11.7.2 Siemens AG Business Overview

11.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Introduction

11.7.4 Siemens AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.7.5 Siemens AG Recent Development

11.8 Roche Holding AG

11.8.1 Roche Holding AG Company Detail

11.8.2 Roche Holding AG Business Overview

11.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Introduction

11.8.4 Roche Holding AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.8.5 Roche Holding AG Recent Development

11.9 Hologic, Inc.

11.9.1 Hologic, Inc. Company Detail

11.9.2 Hologic, Inc. Business Overview

11.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Introduction

11.9.4 Hologic, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.9.5 Hologic, Inc. Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Detail

11.10.2 Qiagen Business Overview

11.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Introduction

11.10.4 Qiagen Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.10.5 Qiagen Recent Development

11.11 Cardinal Health

11.11.1 Cardinal Health Company Detail

11.11.2 Cardinal Health Business Overview

11.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Introduction

11.11.4 Cardinal Health Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.11.5 Cardinal Health Recent Development

11.12 Quest Diagnostics Incorporated

11.12.1 Quest Diagnostics Incorporated Company Detail

11.12.2 Quest Diagnostics Incorporated Business Overview

11.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Introduction

11.12.4 Quest Diagnostics Incorporated Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.12.5 Quest Diagnostics Incorporated Recent Development

11.13 Ador Diagnostics

11.13.1 Ador Diagnostics Company Detail

11.13.2 Ador Diagnostics Business Overview

11.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Introduction

11.13.4 Ador Diagnostics Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.13.5 Ador Diagnostics Recent Development

11.14 Akonni Biosystems, Inc.

11.14.1 Akonni Biosystems, Inc. Company Detail

11.14.2 Akonni Biosystems, Inc. Business Overview

11.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Introduction

11.14.4 Akonni Biosystems, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.14.5 Akonni Biosystems, Inc. Recent Development

11.15 Alveo Technologies

11.15.1 Alveo Technologies Company Detail

11.15.2 Alveo Technologies Business Overview

11.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Introduction

11.15.4 Alveo Technologies Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.15.5 Alveo Technologies Recent Development

11.16 Binx Health Inc.

11.16.1 Binx Health Inc. Company Detail

11.16.2 Binx Health Inc. Business Overview

11.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Introduction

11.16.4 Binx Health Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.16.5 Binx Health Inc. Recent Development

11.17 bioMérieux, Inc.

11.17.1 bioMérieux, Inc. Company Detail

11.17.2 bioMérieux, Inc. Business Overview

11.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Introduction

11.17.4 bioMérieux, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.17.5 bioMérieux, Inc. Recent Development

11.18 Curetis

11.18.1 Curetis Company Detail

11.18.2 Curetis Business Overview

11.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Introduction

11.18.4 Curetis Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.18.5 Curetis Recent Development

11.19 Sysmex Europe GmbH

11.19.1 Sysmex Europe GmbH Company Detail

11.19.2 Sysmex Europe GmbH Business Overview

11.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Introduction

11.19.4 Sysmex Europe GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.19.5 Sysmex Europe GmbH Recent Development

11.20 Diasorin S.p.A

11.20.1 Diasorin S.p.A Company Detail

11.20.2 Diasorin S.p.A Business Overview

11.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Introduction

11.20.4 Diasorin S.p.A Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

11.20.5 Diasorin S.p.A Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Technology (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of PCR

    Table 3. Key Players of Immunodiagnostics

    Table 4. Key Players of Clinical Microbiology

    Table 5. Key Players of INAAT

    Table 6. Key Players of DNA Sequencing and NGS

    Table 7. Key Players of DNA Microarrays

    Table 8. Key Players of Others

    Table 9. Global OTC and DTC Infectious Disease Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region (2018-2023)

    Table 13. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region (2024-2029)

    Table 15. OTC and DTC Infectious Disease Diagnostic Market Trends

    Table 16. OTC and DTC Infectious Disease Diagnostic Market Drivers

    Table 17. OTC and DTC Infectious Disease Diagnostic Market Challenges

    Table 18. OTC and DTC Infectious Disease Diagnostic Market Restraints

    Table 19. Global OTC and DTC Infectious Disease Diagnostic Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global OTC and DTC Infectious Disease Diagnostic Market Share by Players (2018-2023)

    Table 21. Global Top OTC and DTC Infectious Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2022)

    Table 22. Ranking of Global Top OTC and DTC Infectious Disease Diagnostic Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by OTC and DTC Infectious Disease Diagnostic Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players OTC and DTC Infectious Disease Diagnostic Product Solution and Service

    Table 26. Date of Enter into OTC and DTC Infectious Disease Diagnostic Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023) & (US$ Million)

    Table 29. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Technology (2018-2023)

    Table 30. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Technology (2024-2029) & (US$ Million)

    Table 31. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Technology (2024-2029)

    Table 32. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Application (2018-2023)

    Table 34. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Application (2024-2029)

    Table 36. North America OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Abbott Company Detail

    Table 52. Abbott Business Overview

    Table 53. Abbott OTC and DTC Infectious Disease Diagnostic Product

    Table 54. Abbott Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 55. Abbott Recent Development

    Table 56. Bio-Rad Laboratories Inc Company Detail

    Table 57. Bio-Rad Laboratories Inc Business Overview

    Table 58. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product

    Table 59. Bio-Rad Laboratories Inc Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 60. Bio-Rad Laboratories Inc Recent Development

    Table 61. BD Company Detail

    Table 62. BD Business Overview

    Table 63. BD OTC and DTC Infectious Disease Diagnostic Product

    Table 64. BD Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 65. BD Recent Development

    Table 66. Bosch Healthcare Solutions GmbH Company Detail

    Table 67. Bosch Healthcare Solutions GmbH Business Overview

    Table 68. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product

    Table 69. Bosch Healthcare Solutions GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 70. Bosch Healthcare Solutions GmbH Recent Development

    Table 71. Danaher Company Detail

    Table 72. Danaher Business Overview

    Table 73. Danaher OTC and DTC Infectious Disease Diagnostic Product

    Table 74. Danaher Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 75. Danaher Recent Development

    Table 76. ThermoFisher Scientific Company Detail

    Table 77. ThermoFisher Scientific Business Overview

    Table 78. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product

    Table 79. ThermoFisher Scientific Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 80. ThermoFisher Scientific Recent Development

    Table 81. Siemens AG Company Detail

    Table 82. Siemens AG Business Overview

    Table 83. Siemens AG OTC and DTC Infectious Disease Diagnostic Product

    Table 84. Siemens AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 85. Siemens AG Recent Development

    Table 86. Roche Holding AG Company Detail

    Table 87. Roche Holding AG Business Overview

    Table 88. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product

    Table 89. Roche Holding AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 90. Roche Holding AG Recent Development

    Table 91. Hologic, Inc. Company Detail

    Table 92. Hologic, Inc. Business Overview

    Table 93. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product

    Table 94. Hologic, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 95. Hologic, Inc. Recent Development

    Table 96. Qiagen Company Detail

    Table 97. Qiagen Business Overview

    Table 98. Qiagen OTC and DTC Infectious Disease Diagnostic Product

    Table 99. Qiagen Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 100. Qiagen Recent Development

    Table 101. Cardinal Health Company Detail

    Table 102. Cardinal Health Business Overview

    Table 103. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product

    Table 104. Cardinal Health Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 105. Cardinal Health Recent Development

    Table 106. Quest Diagnostics Incorporated Company Detail

    Table 107. Quest Diagnostics Incorporated Business Overview

    Table 108. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product

    Table 109. Quest Diagnostics Incorporated Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 110. Quest Diagnostics Incorporated Recent Development

    Table 111. Ador Diagnostics Company Detail

    Table 112. Ador Diagnostics Business Overview

    Table 113. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product

    Table 114. Ador Diagnostics Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 115. Ador Diagnostics Recent Development

    Table 116. Akonni Biosystems, Inc. Company Detail

    Table 117. Akonni Biosystems, Inc. Business Overview

    Table 118. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product

    Table 119. Akonni Biosystems, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 120. Akonni Biosystems, Inc. Recent Development

    Table 121. Alveo Technologies Company Detail

    Table 122. Alveo Technologies Business Overview

    Table 123. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product

    Table 124. Alveo Technologies Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 125. Alveo Technologies Recent Development

    Table 126. Binx Health Inc. Company Detail

    Table 127. Binx Health Inc. Business Overview

    Table 128. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product

    Table 129. Binx Health Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 130. Binx Health Inc. Recent Development

    Table 131. bioMérieux, Inc. Company Detail

    Table 132. bioMérieux, Inc. Business Overview

    Table 133. bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Product

    Table 134. bioMérieux, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 135. bioMérieux, Inc. Recent Development

    Table 136. Curetis Company Detail

    Table 137. Curetis Business Overview

    Table 138. Curetis OTC and DTC Infectious Disease Diagnostic Product

    Table 139. Curetis Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 140. Curetis Recent Development

    Table 141. Sysmex Europe GmbH Company Detail

    Table 142. Sysmex Europe GmbH Business Overview

    Table 143. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product

    Table 144. Sysmex Europe GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 145. Sysmex Europe GmbH Recent Development

    Table 146. Diasorin S.p.A Company Detail

    Table 147. Diasorin S.p.A Business Overview

    Table 148. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product

    Table 149. Diasorin S.p.A Revenue in OTC and DTC Infectious Disease Diagnostic Business (2018-2023) & (US$ Million)

    Table 150. Diasorin S.p.A Recent Development

    Table 151. Research Programs/Design for This Report

    Table 152. Key Data Information from Secondary Sources

    Table 153. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Technology (2023-2029) & (US$ Million)

    Figure 2. Global OTC and DTC Infectious Disease Diagnostic Market Share by Technology: 2022 VS 2029

    Figure 3. PCR Features

    Figure 4. Immunodiagnostics Features

    Figure 5. Clinical Microbiology Features

    Figure 6. INAAT Features

    Figure 7. DNA Sequencing and NGS Features

    Figure 8. DNA Microarrays Features

    Figure 9. Others Features

    Figure 10. Global OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application: 2022 VS 2029

    Figure 12. Diagnostic Laboratories Case Studies

    Figure 13. Hospitals and Clinics Case Studies

    Figure 14. Academic Research Institutes Case Studies

    Figure 15. Others Case Studies

    Figure 16. OTC and DTC Infectious Disease Diagnostic Report Years Considered

    Figure 17. Global OTC and DTC Infectious Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global OTC and DTC Infectious Disease Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region: 2022 VS 2029

    Figure 20. Global OTC and DTC Infectious Disease Diagnostic Market Share by Players in 2022

    Figure 21. Global Top OTC and DTC Infectious Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by OTC and DTC Infectious Disease Diagnostic Revenue in 2022

    Figure 23. North America OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America OTC and DTC Infectious Disease Diagnostic Market Share by Country (2018-2029)

    Figure 25. United States OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Canada OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe OTC and DTC Infectious Disease Diagnostic Market Share by Country (2018-2029)

    Figure 29. Germany OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. France OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. U.K. OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Italy OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Russia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Nordic Countries OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Share by Region (2018-2029)

    Figure 37. China OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Japan OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. South Korea OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. India OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Australia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America OTC and DTC Infectious Disease Diagnostic Market Share by Country (2018-2029)

    Figure 45. Mexico OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Brazil OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Share by Country (2018-2029)

    Figure 49. Turkey OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Abbott Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 52. Bio-Rad Laboratories Inc Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 53. BD Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 54. Bosch Healthcare Solutions GmbH Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 55. Danaher Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 56. ThermoFisher Scientific Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 57. Siemens AG Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 58. Roche Holding AG Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 59. Hologic, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 60. Qiagen Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 61. Cardinal Health Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 62. Quest Diagnostics Incorporated Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 63. Ador Diagnostics Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 64. Akonni Biosystems, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 65. Alveo Technologies Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 66. Binx Health Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 67. bioMérieux, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 68. Curetis Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 69. Sysmex Europe GmbH Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 70. Diasorin S.p.A Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2018-2023)

    Figure 71. Bottom-up and Top-down Approaches for This Report

    Figure 72. Data Triangulation

    Figure 73. Key Executives Interviewed